Literature DB >> 10389998

The hospital costs of treating lung cancer in the United Kingdom.

J L Wolstenholme1, D K Whynes.   

Abstract

A detailed patient-by-patient costing analysis, based on case records for 253 patients diagnosed in 1993, reveals that the mean 4-year diagnosis and management costs amounted to Pound Sterling 6150 and Pound Sterling 5668 for non-small cell and small cell lung cancer respectively. These costs are lower than those identified in Canadian studies, the difference being explained by the use of a simulated costing methodology in these studies, lower unit costs and less aggressive interventions.

Entities:  

Mesh:

Year:  1999        PMID: 10389998      PMCID: PMC2363001          DOI: 10.1038/sj.bjc.6690341

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Stage-specific treatment costs for cervical cancer in the United Kingdom.

Authors:  J L Wolstenholme; D K Whynes
Journal:  Eur J Cancer       Date:  1998-11       Impact factor: 9.162

2.  Discounting and health benefits.

Authors:  M Parsonage; H Neuburger
Journal:  Health Econ       Date:  1992-04       Impact factor: 3.046

3.  The economics of lung cancer management in Canada.

Authors:  W K Evans; B P Will; J M Berthelot; M C Wolfson
Journal:  Lung Cancer       Date:  1996-02       Impact factor: 5.705

4.  The costs of treating breast cancer in the United Kingdom: implications for screening.

Authors:  J L Wolstenholme; S J Smith; D K Whynes
Journal:  Int J Technol Assess Health Care       Date:  1998       Impact factor: 2.188

5.  On approximations in treatment costing.

Authors:  D K Whynes; A R Walker
Journal:  Health Econ       Date:  1995 Jan-Feb       Impact factor: 3.046

6.  Study of lung cancer treatment costs may point to savings on a broader scale.

Authors:  J Rafuse
Journal:  CMAJ       Date:  1993-10-15       Impact factor: 8.262

Review 7.  The cost of managing lung cancer in Canada.

Authors:  W K Evans; B P Will; J M Berthelot; M C Wolfson
Journal:  Oncology (Williston Park)       Date:  1995-11       Impact factor: 2.990

8.  Cost of patient follow-up after potentially curative lung cancer treatment.

Authors:  K S Virgo; K S Naunheim; L W McKirgan; M E Kissling; J C Lin; F E Johnson
Journal:  J Thorac Cardiovasc Surg       Date:  1996-08       Impact factor: 5.209

9.  Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.

Authors:  W K Evans; B P Will; J M Berthelot; M C Wolfson
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  9 in total
  11 in total

Review 1.  Cost of lung cancer: a methodological review.

Authors:  Laurent Molinier; Christophe Combescure; Cristos Chouaïd; Jean-Pierre Daurès; Bruno Housset; Didier Fabre; Alain Grand; Alain Vergnenègre
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Management and costs of treating lung cancer patients in a university hospital.

Authors:  Konstantin J Dedes; Thomas D Szucs; Stephan Bodis; Markus Joerger; Adam Lowy; Erich W Russi; Hans C Steinert; Walter Weder; Rolf A Stahel
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 3.  Economics of treatments for non-small cell lung cancer.

Authors:  Christos Chouaid; Kukovi Atsou; Gilles Hejblum; Alain Vergnenegre
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  Direct treatment costs for patients with lung cancer from first recurrence to death in france.

Authors:  Anne-Chantal Braud; Christine Lévy-Piedbois; Pascal Piedbois; Youri Piedbois; Alain Livartovski; Béatrice Le Vu; Jean Trédaniel; François Reboul; Yvelise Brewer; Said Talbi; François Blanchon; Britta Paschen; Isabelle Durand-Zaleski
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Is There a Role of Double Reporting and CT Pelvis for Lung Cancer Staging?

Authors:  Rajesh Botchu; Ganesh Retnasingam; Vimal Raj; Mohammad Ali Husainy; George Jakanani; Balaji Rao; James Entwisle
Journal:  World J Oncol       Date:  2012-04-23

6.  Estimated costs of advanced lung cancer care in a public reference hospital.

Authors:  Renata Erthal Knust; Margareth Crisóstomo Portela; Claudia Cristina de Aguiar Pereira; Guilherme Bastos Fortes
Journal:  Rev Saude Publica       Date:  2017-08-17       Impact factor: 2.106

7.  Economic Burden for Lung Cancer Survivors in Urban China.

Authors:  Xin Zhang; Shuai Liu; Yang Liu; Jian Du; Wenqi Fu; Xiaowen Zhao; Weidong Huang; Xianming Zhao; Guoxiang Liu; Zhengzhong Mao; Teh-Wei Hu
Journal:  Int J Environ Res Public Health       Date:  2017-03-15       Impact factor: 3.390

8.  An analysis of the economic impact of smoking cessation in Europe.

Authors:  David Cohen; M Fasihul Alam; Paul S Jarvis
Journal:  BMC Public Health       Date:  2013-04-25       Impact factor: 3.295

9.  Could CT screening for lung cancer ever be cost effective in the United Kingdom?

Authors:  David K Whynes
Journal:  Cost Eff Resour Alloc       Date:  2008-02-26

10.  Economics of the clinical management of lung cancer in France: an analysis using a Markov model.

Authors:  C Chouaïd; L Molinier; C Combescure; J P Daurès; B Housset; A Vergnenègre
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.